Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people ...

Kidney disease is a leading cause of death in America, killing more people than breast cancer or prostate cancer.

One person died in Colorado and four people have developed a potentially life-threatening kidney disease complication. People ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

One person has died and four people have developed a potentially life-threatening kidney disease complication as part of the ...

A new study from Monash University in Australia has found that gabapentinoids—commonly used drugs for treating neuropathic ...

Cases have been detected in 14 states, according to an update from the US Centers for Disease Control and Prevention.

Risks were high for people with chronic kidney disease or significant frailty. Odds of hip fracture remained high after ...

Nearly three decades later, drug makers have developed six approved small interfering RNA (siRNA) therapeutics in the ...

Prokidney Corp. ( (PROK) ) has released its Q3 earnings. Here is a breakdown of the information Prokidney Corp. presented to its investors.

Nearly 300,000 bottles of the drug, named Cinacalcet, were recalled and given a Class II recall risk level by the FDA.